Table 12.12a

Unadjusted Patient Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	2,010	89.5%	0.7%	2,010	80.0%	0.9%	1,765	61.5%	1.2%	1,689	46.0%	1.2%
Primary Diagnosis	Emphysema/COPD	866	92.4%	0.9%	866	84.4%	1.2%	779	64.2%	1.7%	664	46.7%	1.9%
	Cystic Fibrosis	301	91.7%	1.6%	301	82.4%	2.2%	292	64.7%	2.8%	297	50.2%	2.9%
	Idiopathic Pulmonary Fibrosis	366	86.9%	1.8%	366	74.6%	2.3%	279	52.3%	3.0%	260	38.8%	3.0%
	Alpha-1-Antitrypsin Deficiency	160	88.8%	2.5%	160	75.0%	3.4%	134	59.7%	4.2%	160	48.8%	4.0%
	Primary Pulmonary Hypertension	81	75.3%	4.8%	81	71.6%	5.0%	75	56.0%	5.7%	88	43.2%	5.3%
	Congenital Disease	16	75.0%	10.8%	16	75.0%	10.8%	30	60.0%	8.9%	29	37.9%	9.0%
	Other	220	85.9%	2.3%	220	75.0%	2.9%	175	62.3%	3.7%	189	47.1%	3.6%
	Unknown	0	-	-	0	-	-	1	100.0%	0.0%	2	50.0%	35.4%

Source: OPTN/SRTR Data as of May 3, 2004.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during 2001-2002 for 3 month and 1 year; 1999-2000 for 3 year; and 1997-1998 for 5 year survival.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.